Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06465329
Title A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Orchard Healthcare Research Inc. RECRUITING Skokie Illinois 60077 United States Details
Detroit Clinical Research Center RECRUITING Farmington Hills Michigan 48334 United States Details
University of Tennessee Medical Center RECRUITING Knoxville Tennessee 37920 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field